- aTyr Pharma to Participate in Upcoming Investor Conferences
- First-in-Class Oral PKM2 Modulator SYX-5219 Phase 1a Trial Data to be Presented at SID 2026
- Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026
- $127+ Billion Autoinjectors Market by Type, Usage, Actuation Mechanism, Therapy, ROA, Volume and Region - Forecast to 2031
- Algae Products Market to Reach USD 10.43 Billion by 2032, Driven by Expanding Industrial Applications and Versatility Across Multiple End-Use Sectors: - Verified Market Research
- Fortis Life Sciences Awards 2026 AbNanoŽ VHH Discovery Grant to Deliver Biosciences for Targeted Drug Delivery Research
- SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advancing a Differentiated Next-Gen GLP-1 Platform
- Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
- Lyell Immunopharma Announces Participation in May Investor Conferences
- aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting
